We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+12.27%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$456M
AUM Growth
+$68.2M
Cap. Flow
+$32.6M
Cap. Flow %
7.15%
Top 10 Hldgs %
36.84%
Holding
146
New
10
Increased
59
Reduced
35
Closed
4

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$16.1M
2
EBAY icon
eBay
EBAY
+$5.35M
3
CRL icon
Charles River Laboratories
CRL
+$1.55M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.45M
5
COP icon
ConocoPhillips
COP
+$1.16M

Sector Composition

Rank Sector Weight
1 Technology 20.7%
2 Consumer Discretionary 20.22%
3 Financials 12.39%
4 Healthcare 11.49%
5 Industrials 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$213B
$5.33M 1.17%
7,985
-125
-2% -$78K
CACI icon
27
CACI
CACI
$11B
$5.31M 1.16%
19,715
+1,410
+8% +$386K
V icon
28
Visa
V
$684B
$5.22M 1.14%
24,087
+1,400
+6% +$301K
FDX icon
29
FedEx
FDX
$72.7B
$5.14M 1.13%
19,893
+965
+5% +$232K
TJX icon
30
TJX Companies
TJX
$174B
$4.68M 1.03%
61,690
+4,290
+7% +$298K
SBUX icon
31
Starbucks
SBUX
$120B
$4.67M 1.02%
39,892
+4,925
+14% +$555K
ORCL icon
32
Oracle
ORCL
$374B
$4.59M 1.01%
52,637
BAC icon
33
Bank of America
BAC
$435B
$4.42M 0.97%
99,313
+6,583
+7% +$300K
BMY icon
34
Bristol-Myers Squibb
BMY
$133B
$4.13M 0.91%
66,272
+1,825
+3% +$107K
LMT icon
35
Lockheed Martin
LMT
$134B
$4.11M 0.9%
11,550
+170
+1% +$58.8K
NVO
36
Novo Nordisk
NVO
$208B
$3.96M 0.87%
70,650
-250
-0.4% -$13.5K
GOOGL icon
37
Alphabet (Google) Class A
GOOGL
$4.36T
$3.93M 0.86%
27,140
+2,960
+12% +$426K
INTC icon
38
Intel
INTC
$455B
$3.7M 0.81%
71,773
+1,750
+2% +$89.5K
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.68M 0.81%
12,304
-100
-0.8% -$28.6K
WM icon
40
Waste Management
WM
$90.6B
$3.57M 0.78%
21,380
PCH
41
DELISTED
PotlatchDeltic
PCH
$3.39M 0.74%
56,350
+1,900
+3% +$107K
MAR icon
42
Marriott International
MAR
$98.3B
$3.33M 0.73%
20,150
+1,200
+6% +$189K
HOLX
43
DELISTED
Hologic
HOLX
$3.21M 0.7%
41,950
+2,800
+7% +$206K
JNJ icon
44
Johnson & Johnson
JNJ
$618B
$3.14M 0.69%
18,341
+825
+5% +$135K
CAT icon
45
Caterpillar
CAT
$375B
$3.02M 0.66%
14,588
+100
+0.7% +$20.1K
CI icon
46
Cigna
CI
$73.7B
$2.89M 0.63%
12,566
-317
-2% -$67.4K
CVS icon
47
CVS Health
CVS
$133B
$2.88M 0.63%
27,912
-1,075
-4% -$99.3K
HON icon
48
Honeywell
HON
$77B
$2.86M 0.63%
14,537
-53
-0.4% -$10.7K
GEN icon
49
Gen Digital
GEN
$16.4B
$2.75M 0.6%
106,000
+8,100
+8% +$205K
RIO icon
50
Rio Tinto
RIO
$158B
$2.65M 0.58%
39,640
+7,015
+22% +$454K

Similar funds

EagleClaw Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, EagleClaw Capital Management held 146 positions worth $456M, up 18% from $388M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

EagleClaw Capital Management deployed $32.6M of net new capital in Q4 2021, opening 10 new positions and adding to 59 existing holdings. Its largest new stake was eBay: 75,000 shares worth $75K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2M trimmed.

  • EagleClaw Capital Management's largest Q4 2021 buy was eBay: 75,000 shares worth $75K.
  • EagleClaw Capital Management added most to Nike in Q4 2021, an estimated $16.1M increase.
  • EagleClaw Capital Management's biggest Q4 2021 reduction was Gilead Sciences, cutting an estimated $2M.
  • EagleClaw Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $467K.
  • EagleClaw Capital Management's ten largest holdings make up 37% of its $456M portfolio in Q4 2021.
  • EagleClaw Capital Management opened 10 new positions and closed 4 in Q4 2021.
  • EagleClaw Capital Management's portfolio value rose 18% quarter-over-quarter to $456M.

Based on EagleClaw Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.